A rare and overlooked cause of massive gastrointestinal bleeding: Distal duodenal GIST
DOI:
https://doi.org/10.15584/ejcem.2021.2.12Keywords:
duodenum, gastrointestinal stromal tumor, GIST, massive gastrointestinal bleedingAbstract
Introduction. Gastrointestinal stromal tumors(GIST) are tumors of mesenchymal origin which originate from the walls of gastrointestinal system (GIS) organs.
Aim. In this case report we aim to discuss the clinical, labaratory and radiological presentation of distal duodenal GIST as a rare and overlooked cause of life-threatining GIS bleeding.
Description of the case. A 76-year-old male patient was presented to the emergency department with massive gastrointestinal bleeding. Computerized tomography revealed a mass soft tissue density of 4x4cm at the level of the 3-4th segment of the duodenum. At the endoscopy, there was a deep ulcer in the proximal part of the 3rd segment of the duodenum with a diameter of 2 cm with a bleeding vessel protruding into the lumen. After endoscopic treatments, biopsies were taken from the edges of the ulcer. Histopathological examination revealed a sheet-like infiltration composed of mildly pleomorphic cells with oval-spindle nuclei and abundant eosinophilic cytoplasm in the duodenal lamina propria, as the patient was diagnosed of GIST.
Conclusion. GIST and its clinical, labaratory and radiological presentation should be kept in mind in the approach to massive duodenal GIS bleeding.
Downloads
References
Ahmed M. Recent advances in the management of gastrointestinal stromal tumor. World J Clin Cases. 2020;8(15):3142-3155.
Landi B, Blay JY, Bonvalot S, et al. Gastrointestinal stromal tumours (GISTs): French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up. Dig Liver Dis. 2019;51(9):1223-1231.
Parab TM, DeRogatis MJ, Boaz AM, et al. Gastrointestinal stromal tumors: a comprehensive review. J Gastrointest Oncol. 2019;10(1):144-154.
Iorio N, Sawaya RA, Friedenberg FK. Review article: the biology, diagnosis and management ofgastrointestinal stromal tumours. Aliment Pharmacol Ther. 2014;39:1376-1386.
Mantese G. Gastrointestinal stromal tumor: epidemiology, diagnosis, and treatment. Curr Opin Gastroenterol. 2019;35(6):555-559.
Zhang H, Liu Q. Prognostic Indicators for Gastrointestinal Stromal Tumors: A Review. Transl Oncol. 2020;13(10):100812. doi: 10.1016/j.tranon.2020.100812.
Krishnamurthy G, Singh H, Sharma V, Savlania A, Vasishta RK. Therapeutic Challenges in the Management of Bleeding Duodenal Gastrointestinal Stromal Tumor: a Case Report and Review of Literature. J Gastrointest Cancer. 2019;50(1):170-174.
ESMO/European Sarcoma Network Working Group. Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23 Suppl 7:vii49-55.
Atak T, Eren TT, Burcu B, Sağıroğlu J, Özemir IA, Alimoğlu O. Gastrointestinal stromal tumors: Retrospective analysis of 21 cases. Haydarpaşa Numune Medical Journal, 2019;vol.59:157-161.
Akif Aydın, Mehmet Altan Kaya, Süleyman Bozkurt, Faik Çelik. Gastrointestinal Stromal Tumours (GIST)- Respect to a Patient With Acute Abdomen. Medeniyet Med J. 2001;16(2):121-123.
Akbaş A, Bakır H, Dagmura H, et al. Management of Gastrointestinal Stromal Tumors: Experience of a University Hospital. Bozok Med J. 2020;10(2):137-144.
Tanoğlu A, Beyazıt Y, Düzenli T. Üst gastrointestinal sistem kanaması şeklinde prezente olan dev gastrointestinal stromal tümör. CausaPedia. 2019;8(3):98-102.
Bülbül Doğusoy G; Turkish GIST Working Group. Gastrointestinal stromal tumors: A multicenter study of 1160 Turkish cases. Turk J Gastroenterol. 2012;23(3):203-211
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
